SCHEMBL671608

SCHEMBL671608

C=CC[C](N)C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8708031 0.72
SCHEMBL29622 0.69
SCHEMBL27977614 0.69 ALDH1A1 (0.33)
SCHEMBL5616890 0.68 GRIK1 (0.36)
Acrylamide SCHEMBL27801163 0.67 ALDH1A1 (0.61)
SCHEMBL28992671 0.67
SCHEMBL28147528 0.67
SCHEMBL22988 0.67
SCHEMBL458821 0.67
SCHEMBL6167960 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2293 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239794-A1 PKC-Theta Modulators EXSCIENTIA AI LIMITED (GB) 2024-07-18 US claimed
CN-117794898-A 3-pyrrolylsulfonamide compounds as GPR17 antagonists 瑞文德医疗公众有限公司 2024-03-29 CN claimed
EP-4334316-A1 PKC-THETA MODULATORS Exscientia Al Limited (GB) 2024-03-13 EP claimed
EP-4333982-A1 PKC-THETA MODULATORS Exscientia Al Limited (GB) 2024-03-13 EP claimed
CN-117355507-A Pyrimidine derivatives as LRRK2 kinase inhibitors 哈利亚治疗公司 2024-01-05 CN claimed
WO-2023248255-A1 BETA CARBOLINE ANALOGUES AS SELECTIVE AND BIASED KAPPA OPIOID RECEPTORS AGONISTS FOR TREATING VARIOUS ASSOCIATED PATHOPHYSIOLOGICAL CONDITIONS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2023-12-28 WO claimed
CN-116963733-A Imidazole compounds as ENPP1 inhibitors 斯汀格瑞治疗股份有限公司 2023-10-27 CN claimed
EP-4247492-A1 MALT-1 MODULATORS Exscientia Al Limited (GB) 2023-09-27 EP claimed
CN-116535365-A Macrocyclic diamine derivatives and their combination with adenosine receptor antagonists as ENT inhibitors for the treatment of cancer ITEOS比利时公司 2023-08-04 CN claimed
WO-2023147161-A2 NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF New Frontier Bio, Inc. (US) 2023-08-03 WO claimed
CN-86105509-A Benzoates 1987-02-11 CN claimed
EP-0086774-A1 TREATMENT OF COCCIDIAL INFECTIONS WITH AMIDINOUREA OR AMIDINOTHIOUREA DERIVATIVES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1983-08-31 EP claimed
WO-1983000625-A1 TREATMENT OF COCCIDIAL INFECTIONS WITH AMIDINOUREA OR AMIDINOTHIOUREA DERIVATIVES STUDT, WILLIAM, LYON 1983-03-03 WO claimed
EP-0026221-A4 DYSMENORRHEA TREATMENT. RORER INC WILLIAM H (US) 1981-08-27 EP claimed
US-4279928-A Method of lowering blood pressure WILLIAM H. RORER, INC. (US) 1981-07-21 US claimed
EP-0026221-A1 DYSMENORRHEA TREATMENT WILLIAM H. RORER, INC. (US) 1981-04-08 EP claimed
US-4241087-A AMIDINOUREAS WILLIAM H. RORER, INC. (US) 1980-12-23 US claimed
US-4233241-A LEUCO INDOANILINE DYES FOR HAIR L'OREAL (FR) 1980-11-11 US claimed
WO-1980002110-A1 DYSMENORRHEA TREATMENT RORER INC WILLIAM H (US) 1980-10-16 WO claimed
US-4009271-A 6-AZA-3H-1,4-BENZODIAZEPINES DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1977-02-22 US claimed